Skip to main content
We may receive compensation from affiliate partners for some links on this site. Read our full Disclosure here.

B*yer *merges For DNA T*sting C*mpany 23*ndMe


Regeneron Pharmaceuticals said on Monday it would buy 23andMe out of bankruptcy for $256 million.

The acquisition gives Regeneron the company’s genetic samples and data for millions of individuals.

Regeneron Pharmaceuticals to buy 23andMe for $256M — taking control of genetic data of millions https://t.co/wh3uEsfQH7 pic.twitter.com/1bg9I6tUzi

— New York

Continue reading


 

Join the conversation!

Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!

Leave a comment
Thanks for sharing!